Viemed(VMD) - 2022 Q3 - Quarterly Report
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT British Columbia, Canada N/A (State or other jurisdiction of incorporation or organization) (IRS Employer Identification Number) 625 E. Kaliste Saloom Rd. Lafayette, LA 70508 (Address of principal executive ...